Leg Heat Therapy in Peripheral Artery Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorIndiana University

About this trial

The goal of this randomized, double-blind, sham-controlled clinical trial is to evaluate the benefits of home-based, leg heat therapy (HT) on lower-extremity functioning and quality of life in patients who suffer from lower-extremity peripheral artery disease (PAD). We will randomize 106 patients to one of two groups that either receive leg HT or a sham intervention. The primary study outcome is the change in 6-minute walk distance between baseline and the 12-week follow up. Secondary outcomes include changes in the short physical performance battery score, handgrip strength, quality of life (measured by the Walking Impairment Questionnaire and Short-Form (SF)-36 Questionnaire), calf muscle strength (measured using a calf ergometer), size (measured by magnetic resonance imaging) and bioenergetics (assessed using phosphorus-31 magnetic resonance spectroscopy), and physical activity (measured by accelerometer).

Eligibility criteria

Qualifiers

Men and women older than 50 years

Resting ankle-brachial index (ABI) of 0.9 or less in at least one leg. Individuals with a resting ABI between 0.91 and 1.00 at baseline will be eligible if their ABI drops by 20% or greater following a heel-rise test.

Disqualifiers

Critical limb ischemia (ischemic rest pain or ischemia-related, non-healing wounds or tissue loss)

Prior foot or leg amputation

Exercise tolerance limited by factors other than leg pain (e.g. angina, arthritis, severe lung disease, etc).

Recent (<3 months) lower-extremity revascularization or orthopedic surgery

Trial design

Treatments tested in this trial

  • Leg heat therapy
  • Sham Control

Treatment groups

106 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Indiana University

Lead sponsor

Purdue University

Collaborator

National Institute on Aging (NIA)

Collaborator